JATT (JATT) Stock Price & Analysis

JATT (JATT) rose 3.29% to USD 11.31 as of July 26, 2026 at 11:54 UTC, according to Nexqual real-time market data.

JATT last closed at USD 10.95; the session ranged USD 10.91–12.2 on volume of 17,628 shares. Market capitalization is $90.76M, with a 52-week range of USD 9.99–12.63 (NGM). Source: Nexqual, July 26, 2026 at 11:54 UTC.

Key Statistics (as of July 26, 2026 at 11:54 UTC)

PriceUSD 11.31
Change▲ 3.29% (up)
Previous CloseUSD 10.95
OpenUSD 11.91
Day RangeUSD 10.91 – 12.2
52-Week RangeUSD 9.99 – 12.63
Volume17,628 shares
Market Cap$90.76M
ExchangeNGM

Technical Analysis (JATT)

Nexqual's technical model rates JATT "STRONG BUY" based on 5 bullish and 0 bearish signals across 68 daily candles, as of July 26, 2026 at 11:54 UTC.

Overall SignalSTRONG BUY
RSI (14)55.84 (neutral)
vs SMA50Above (USD 10.88)
MACD0.04 (positive)

Analyst Ratings (JATT)

Wall Street analysts rate JATT "None", per Nexqual as of July 26, 2026 at 11:54 UTC.

Consensus RatingNone

Earnings (JATT)

Source: Nexqual, July 26, 2026 at 11:54 UTC.

Financials & Fundamentals (JATT)

Gross Margin+0.00%
Operating Margin+0.00%
Profit Margin+0.00%
Total Debt$106,141

Source: Nexqual, July 26, 2026 at 11:54 UTC.

Financial Health Score (JATT)

Nexqual rates JATT's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 11:54 UTC.

GrowthMixed — No data
ProfitabilityWeak — Gross margin 0%, operating 0%
Balance SheetMixed — No data
Cash FlowMixed — No data
EfficiencyMixed — No data

Ownership (JATT)

Insider Ownership+23.05%
Institutional Ownership+20.52%
Shares Outstanding8.03M
Short % of Float+0.06%

Source: Nexqual, July 26, 2026 at 11:54 UTC.

Leadership (JATT)

JATT is led by Someit Sidhu (age 36), Founder, Chairman & CEO, per Nexqual as of July 26, 2026 at 11:54 UTC.

Founder, Chairman & CEOSomeit Sidhu (age 36)
CFO & COONicholas Fernandez (age 41)

Major Backers & Investors (JATT)

Notable institutional backers of JATT include Franklin Strategic Series-Franklin Biotechnology Discovery Fund, according to Nexqual as of July 26, 2026 at 11:54 UTC.

Active Investors

InvestorStake
Franklin Strategic Series-Franklin Biotechnology Discovery Fund1.83%

Source: Nexqual, July 26, 2026 at 11:54 UTC.

Peers & Related Stocks

SymbolNamePriceChange
MTALMetals Acquisition Corp. IIUSD 10.21▲ 0.39%
PONOPono Capital Four, Inc.USD 9.96▼ 0.1%
GPACGeneral Purpose Acquisition CorUSD 10.01▲ 0%
TWLVTwelve Seas Investment Company USD 10.02▲ 0.3%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 11:54 UTC. This page is informational and not investment advice.